Current health news highlights a planned IPO by Medline Industries aiming to exceed $5 billion, a second Australian death from methanol poisoning in Laos, GSK's RSV vaccine approval in Japan, and ...
Hosted on MSN1d
Is GSK a bargain now the share price is near 1,333p?The GSK (LSE:GSK) share price has fallen off its perch. So it may be a good time to research and consider the stock ...
GSK said on Friday that its respiratory syncytial virus (RSV) vaccine has received approval in Japan for expanded use in ...
AnaptysBio’s drug candidates rosnilimab and ANB032 hold key trial results ahead. Find out why ANAB stock is impacted by ...
Samsung Biologics has announced another significant manufacturing agreement, securing a $668m contract with a Europe-based ...
Recognizing that the available participant population for rare disease studies is often extremely limited and dispersed globally, GSK welcomed an innovative approach to expanding trial access—one that ...
However, to enhance diversity, companies must adopt a more “youth-ready and youth-friendly approach,” says Matt Lent, chief ...
GSK plc (NYSE:GSK – Get Free Report) was the recipient of unusually large options trading activity on Tuesday. Stock traders acquired 26,518 call options on the stock. This represents an increase of ...
A judge in the U.K. last month sided with Pfizer over GSK in a respiratory syncytial virus vaccine patent lawsuit, ...
We recently compiled a list of the 10 Best German Stocks To Buy Now. In this article, we are going to take a look at where ...
GSK's phase 3 GLISTEN trial demonstrated linerixibat's potential to treat relentless itch in PBC patients, meeting its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback